Phosphatidylinositol 3-kinase (PI3K) Alpha iNhibition In Advanced Breast Cancer

NCT02506556 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

38

Enrollment

OTHER

Sponsor class

Conditions

Metastatic Breast Cancer

Interventions

DRUG: BYl719

Sponsor

Peter MacCallum Cancer Centre, Australia

Collaborators

[object Object]